SCHEMBL23640769

SCHEMBL23640769

CCCCCCCCCCCc1ccc(OCCOS(C)(=O)=O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.59
USP2 O75604 1/20 0.59
ALDH1A1 P00352 1/20 0.59
LMNA P02545 1/20 0.59
CYP3A4 P08684 1/20 0.59
MAPK1 P28482 1/20 0.59
CASP1 P29466 1/20 0.59
KMT2A Q03164 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
SLCO1B3 Q9NPD5 1/20 0.59
SLCO1B1 Q9Y6L6 1/20 0.59
S1PR1 P21453 3/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
PLA2G4A P47712 1/20 0.48
CA2 P00918 2/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
TSHR P16473 1/20 0.46
CA7 P43166 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8498063 0.90 NPC1 (0.54) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL6620386 0.89 CA12 (0.50) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL15923120 0.89 NPC1 (0.59) LMNANPC1RAB9APLA2G4ACA2
SCHEMBL8692164 0.88 MEN1 (0.59) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL17772833 0.87 MEN1 (0.62) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL12245609 0.87 MEN1 (0.62) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL4293936 0.86 CA2 (0.53) MEN1ALDH1A1LMNACYP3A4KMT2A
SCHEMBL6283133 0.86 CA2 (0.53) USP2ALDH1A1LMNACYP3A4SMN1; SMN2
SCHEMBL6285812 0.86 CA2 (0.53) USP2ALDH1A1LMNACYP3A4SMN1; SMN2
SCHEMBL34472572 0.86 MAPK1 (0.57) MEN1USP2ALDH1A1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11639327-B2 Polymerizable compound, and liquid crystal composition and liquid crystal display device using the same DIC CORPORATION (JP) 2023-05-02 US disclosed
US-11639327-B2 Polymerizable compound, and liquid crystal composition and liquid crystal display device using the same DIC CORPORATION (JP) 2023-05-02 US disclosed
US-20210214299-A1 POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME DIC CORPORATION (JP) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214299-A1 POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME SKP1, PKN1, KTN1 MEN1 2210/4885USP2 2818/4885ALDH1A1 3442/4885
US-11639327-B2 Polymerizable compound, and liquid crystal composition and liquid crystal display device using the same SKP1, PKN1, KTN1 MEN1 2210/4885USP2 2818/4885ALDH1A1 3442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.